These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20826913)

  • 21. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification.
    Camaggi CM; Zavatto E; Gramantieri L; Camaggi V; Strocchi E; Righini R; Merina L; Chieco P; Bolondi L
    Clin Chem Lab Med; 2010 Sep; 48(9):1319-26. PubMed ID: 20509833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
    Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors.
    Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Qiao M; Xia L; Mao Y
    Med Sci Monit; 2017 Apr; 23():1636-1644. PubMed ID: 28376075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera.
    Yang G; Cui T; Wang Y; Sun S; Ma T; Wang T; Chen Q; Li Z
    Proteomics; 2013 May; 13(9):1481-98. PubMed ID: 23436760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics study of hepatocellular carcinoma: discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry.
    Zeng J; Yin P; Tan Y; Dong L; Hu C; Huang Q; Lu X; Wang H; Xu G
    J Proteome Res; 2014 Jul; 13(7):3420-31. PubMed ID: 24853826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of proteomic components of sera from patients with hepatocellular carcinomas by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time of flying mass spectrometry].
    Wang Z; Ruan YB; Guan Y
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):333-6. PubMed ID: 14514378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma.
    Na K; Lee EY; Lee HJ; Kim KY; Lee H; Jeong SK; Jeong AS; Cho SY; Kim SA; Song SY; Kim KS; Cho SW; Kim H; Paik YK
    Proteomics; 2009 Aug; 9(16):3989-99. PubMed ID: 19658107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
    Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
    J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.
    Cui J; Kang X; Dai Z; Huang C; Zhou H; Guo K; Li Y; Zhang Y; Sun R; Chen J; Li Y; Tang Z; Uemura T; Liu Y
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):825-34. PubMed ID: 17516088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of human hepatocellular carcinoma-related proteins by proteomic approaches.
    Yang MH; Tyan YC; Jong SB; Huang YF; Liao PC; Wang MC
    Anal Bioanal Chem; 2007 Jun; 388(3):637-43. PubMed ID: 17447055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS.
    Kang X; Sun L; Guo K; Shu H; Yao J; Qin X; Liu Y
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1151-9. PubMed ID: 20130913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
    Tanabe K; Kitagawa K; Kojima N; Iijima S
    J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
    Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the differentially expressed low molecular weight peptides in human serum via an N-terminal isotope labeling technique combining nano-liquid chromatography/matrix-assisted laser desorption/ionization mass spectrometry.
    Leng J; Zhu D; Wu D; Zhu T; Zhao N; Guo Y
    Rapid Commun Mass Spectrom; 2012 Nov; 26(21):2555-62. PubMed ID: 23008073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peak selection from MALDI-TOF mass spectra using ant colony optimization.
    Ressom HW; Varghese RS; Drake SK; Hortin GL; Abdel-Hamid M; Loffredo CA; Goldman R
    Bioinformatics; 2007 Mar; 23(5):619-26. PubMed ID: 17237065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of glycation and glycation sites of lysozyme by matrix-assisted laser desorption/ionization time of flight/time-of-flight mass spectrometry and Liquid chromatography-electrospray ionization tandem mass spectrometry.
    Ruan ED; Wang H; Ruan Y; Juáreza M
    Eur J Mass Spectrom (Chichester); 2014; 20(4):327-36. PubMed ID: 25420345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads.
    Tao YL; Li Y; Gao J; Liu ZG; Tu ZW; Li G; Xu BQ; Niu DL; Jiang CB; Yi W; Li ZQ; Li J; Wang YM; Cheng ZB; Liu QD; Bai L; Zhang C; Zhang JY; Zeng MS; Xia YF
    J Cell Biochem; 2012 Jul; 113(7):2268-78. PubMed ID: 22334501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.